Next Article in Journal
Enhanced Thermal Stability and Conductivity of FeF3 Using Ni-Coated Carbon Composites: Application as High-Temperature Cathodes in Thermal Batteries
Previous Article in Journal
Facile Fabrication of Nickel Supported on Reduced Graphene Oxide Composite for Oxygen Reduction Reaction
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nanomaterials
Volume 13
Issue 24
10.3390/nano13243088
nanomaterials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Nanomaterials 2021, 11(2), 391.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391

by
Debora Santonocito
1,†,
Giuseppina Raciti
1,†,
Agata Campisi
1,
Giovanni Sposito
1,
Annamaria Panico
1,
Edy Angela Siciliano
1,
Maria Grazia Sarpietro
1,
Elisabetta Damiani
2 and
Carmelo Puglia
1,*
1
Department of Drug Science and Health, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy
2
Department of Life and Environmental Sciences, Polytechnic University of Marche, 60121 Ancona, Italy
*
Author to whom correspondence should be addressed.
†
These authors equally contributed to the work.
Nanomaterials 2023, 13(24), 3088; https://doi.org/10.3390/nano13243088
Submission received: 27 July 2023 / Accepted: 25 October 2023 / Published: 6 December 2023
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in Figure 3b as published. An error was committed during the preparation of the manuscript “Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization”, in which the image in Figure 3b is similar to Figure 2a from another article, “Curcumin Containing PEGylated Solid Lipid Nanoparticles for Systemic Administration: A Preliminary Study” published in Molecules. The corrected Figure 3b appears below.
Nanomaterials 13 03088 i001
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the academic editor. The original publication has also been updated.

Reference

  1. Santonocito, D.; Raciti, G.; Campisi, A.; Sposito, G.; Panico, A.; Siciliano, E.A.; Sarpietro, M.G.; Damiani, E.; Puglia, C. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Santonocito, D.; Raciti, G.; Campisi, A.; Sposito, G.; Panico, A.; Siciliano, E.A.; Sarpietro, M.G.; Damiani, E.; Puglia, C. Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391. Nanomaterials 2023, 13, 3088. https://doi.org/10.3390/nano13243088

AMA Style

Santonocito D, Raciti G, Campisi A, Sposito G, Panico A, Siciliano EA, Sarpietro MG, Damiani E, Puglia C. Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391. Nanomaterials. 2023; 13(24):3088. https://doi.org/10.3390/nano13243088

Chicago/Turabian Style

Santonocito, Debora, Giuseppina Raciti, Agata Campisi, Giovanni Sposito, Annamaria Panico, Edy Angela Siciliano, Maria Grazia Sarpietro, Elisabetta Damiani, and Carmelo Puglia. 2023. "Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391" Nanomaterials 13, no. 24: 3088. https://doi.org/10.3390/nano13243088

APA Style

Santonocito, D., Raciti, G., Campisi, A., Sposito, G., Panico, A., Siciliano, E. A., Sarpietro, M. G., Damiani, E., & Puglia, C. (2023). Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391. Nanomaterials, 13(24), 3088. https://doi.org/10.3390/nano13243088

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop